POINT BIOPHARMA GLOBAL INC

$8.00 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About POINT BIOPHARMA GLOBAL INC

POINT Biopharma Global Inc. operates as a clinical-stage global pharmaceutical company. The Company focuses on the development and commercialization of radioligand therapies for the treatment of cancer. POINT Biopharma Global serves customers worldwide.

Stock Analysis

last close $7.97
1-mo return -17.2%
3-mo return -8.2%
avg daily vol. 274.49T
52-week high 18.08
52-week low 6.64
market cap. $718M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 31.3%
baraka

Subscribe now for daily local and international financial news

Subscribe